Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingping Su

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Bioorganic Chemistry|June 27, 2022
Design, synthesis and biological evaluation of a series of novel pyrrolo[2,3-d]pyrimidin/pyrazolo[3,4-d]pyrimidin-4-amine derivatives as FGFRs-dominant multi-target receptor tyrosine kinase inhibitors for the treatment of gastric cancerXiuli Wu, Zhihao Liu, Cailin Gan, et al.
RSC Advances|April 28, 2022
Synthesis and biological evaluation of indazole derivatives as anti-cancer agentsWei Wei, Zhihao Liu, Xiuli Wu, et al.
Biochemical Pharmacology|August 30, 2019
Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathwayYongxia Zhu, Weiqiong Zuo, Lijuan Chen, et al.
European Journal of Medicinal Chemistry|January 7, 2025
Design, synthesis, and biological evaluation of a potent and orally bioavailable FGFRs inhibitor for fibrotic treatmentLin Yue, Zui Tan, Wei Wei, et al.
Phytotherapy Research : PTR|October 17, 2024
Polyphyllin VI Ameliorates Pulmonary Fibrosis by Suppressing the MAPK/ERK and PI3K/AKT Signaling Pathways via Upregulating DUSP6Yuting Xie, Cailing Gan, Hongyao Liu, et al.
Journal of Medicinal Chemistry|February 19, 2021
Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2Zhihao Liu, Xi Hu, Qiwei Wang, et al.
Journal of Medicinal Chemistry|May 19, 2025
Discovery of a Potent FLT3 Inhibitor (<i>E</i>)-4-(3-(3-Fluoro-4-(morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)pyridin-2-amine for the Treatment of Acute Myeloid Leukemia with Multiple FLT3 MutationsZhihao Liu, Ying Xu, Wei Wei, et al.
Cell Proliferation|June 14, 2021
A novel multikinase inhibitor SKLB-YTH-60 ameliorates inflammation and fibrosis in bleomycin-induced lung fibrosis mouse modelsHongyao Liu, Xiuli Wu, Cailing Gan, et al.
Cell Metabolism|August 7, 2024
Dopaminylation of endothelial TPI1 suppresses ferroptotic angiocrine signals to promote lung regeneration over fibrosisChunheng Mo, Hui Li, Mengli Yan, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bioorganic Chemistry|June 27, 2022
Design, synthesis and biological evaluation of a series of novel pyrrolo[2,3-d]pyrimidin/pyrazolo[3,4-d]pyrimidin-4-amine derivatives as FGFRs-dominant multi-target receptor tyrosine kinase inhibitors for the treatment of gastric cancerXiuli Wu, Zhihao Liu, Cailin Gan, et al.
RSC Advances|April 28, 2022
Synthesis and biological evaluation of indazole derivatives as anti-cancer agentsWei Wei, Zhihao Liu, Xiuli Wu, et al.
Biochemical Pharmacology|August 30, 2019
Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathwayYongxia Zhu, Weiqiong Zuo, Lijuan Chen, et al.
European Journal of Medicinal Chemistry|January 7, 2025
Design, synthesis, and biological evaluation of a potent and orally bioavailable FGFRs inhibitor for fibrotic treatmentLin Yue, Zui Tan, Wei Wei, et al.
Phytotherapy Research : PTR|October 17, 2024
Polyphyllin VI Ameliorates Pulmonary Fibrosis by Suppressing the MAPK/ERK and PI3K/AKT Signaling Pathways via Upregulating DUSP6Yuting Xie, Cailing Gan, Hongyao Liu, et al.
Journal of Medicinal Chemistry|February 19, 2021
Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2Zhihao Liu, Xi Hu, Qiwei Wang, et al.
Journal of Medicinal Chemistry|May 19, 2025
Discovery of a Potent FLT3 Inhibitor (<i>E</i>)-4-(3-(3-Fluoro-4-(morpholinomethyl)styryl)-1<i>H</i>-indazol-6-yl)pyridin-2-amine for the Treatment of Acute Myeloid Leukemia with Multiple FLT3 MutationsZhihao Liu, Ying Xu, Wei Wei, et al.
Cell Proliferation|June 14, 2021
A novel multikinase inhibitor SKLB-YTH-60 ameliorates inflammation and fibrosis in bleomycin-induced lung fibrosis mouse modelsHongyao Liu, Xiuli Wu, Cailing Gan, et al.
Cell Metabolism|August 7, 2024
Dopaminylation of endothelial TPI1 suppresses ferroptotic angiocrine signals to promote lung regeneration over fibrosisChunheng Mo, Hui Li, Mengli Yan, et al.
Pageof 2